findmyKOL

Carey Farquhar, MDM, MPH

Basic profile

Washington State Department of Health

ORCIDNPI
RegionSeattle, WA · WestSpecialtyInfectious DiseaseFocusInfectious Disease
Last active 2024findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2020Online presenceNot yet checkedPaymentsNone reportedNIH funding2002–2024Why? →

Carey Farquhar is an Infectious Disease physician affiliated with Washington State Department of Health. OpenAlex indexes 401 publications with 13,124 citations (h-index 51); ClinicalTrials.gov lists 7 registered studies matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
401publications

Distinct works indexed by OpenAlex, matched via ORCID.

13,124citations

Total citations across indexed works.

51h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
7clinical trials

Investigator role on registered studies.

View trials
12NIH grants · 2002–2024

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

325 9th Ave
Seattle, WA 981042499

Telephone

206-744-3000

Registry record last updated 5 Jan 2012.

View the NPPES registry record

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    36.5%
    Statin13.7%
    Rosuvastatin Calcium51%Atorvastatin Calcium49%
    Part D<11 patients
    Beta blocker6%
    Metoprolol Succinate68%Atenolol32%
    Part D<11 patients

    + 5 more classes in this area

  • Metabolism & gastrointestinal

    20.7%
    Proton pump inhibitor8.1%
    Omeprazole42%Pantoprazole Sodium34%Esomeprazole Magnesium24%
    Part D<11 patients
    GLP-1 receptor agonist3.6%
    Rybelsus50%Trulicity50%
    Part D<11 patients

    + 3 more classes in this area

  • Anti-infectives

    17.4%
    Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor7.2%
    Tivicay73%Juluca27%
    Part D<11 patients
    Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor6.4%
    Descovy64%Triumeq36%
    Part D<11 patients

    + 2 more classes in this area

Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

12 NIH research awards on record, funded 20022024 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”